Maria Simonelli

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Andrea Ciarmiello, Milena Cannella, Secondo Lastoria et al. · PubMed · 2006 · 299 citations

Life Sciences, Neurology, Neuroscience +17

Short-term effects of olanzapine in Huntington disease.

Ferdinando Squitieri, Milena Cannella, Antonio Porcellini et al. · PubMed · 2001 · 95 citations

Medicine, Pharmacotherapy, Psychiatry +15

Distinct Brain Volume Changes Correlating with Clinical Stage, Disease Progression Rate, Mutation Size, and Age at Onset Prediction as Early Biomarkers of Brain Atrophy in Huntington's Disease

Ferdinando Squitieri, Milena Cannella, Maria Simonelli et al. · CNS Neuroscience & Therapeutics · 2009 · 80 citations

Life Sciences, Neurology, Neuroscience +17

Clinical manifestations of intermediate allele carriers in Huntington disease

Esther Cubo, María A. Ramos-Arroyo, Saül Martínez‐Horta et al. · Neurology · 2016 · 54 citations

Life Sciences, Genetics, Neurology +13

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

Paul McNulty, Richard Pilcher, Renata Necuiniate et al. · Journal of Huntington s Disease · 2018 · 37 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16